In a trial in China, about 14% of severe COVID-19 patients taking remdesivir died, compared with 13% of those who got a placebo, STAT News reported.
from Yahoo News - Latest News & Headlines https://ift.tt/350dqmD
Labels: Yahoo News - Latest News & Headlines
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home